IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA)
CUSIP: 462260100
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 395,322,451
- Total 13F shares
- 235,201,336
- Share change
- +1,689,090
- Total reported value
- $2,210,596,727
- Put/Call ratio
- 45%
- Price per share
- $9.39
- Number of holders
- 280
- Value change
- +$25,452,589
- Number of buys
- 139
- Number of sells
- 123
Quarterly Holders Quick Answers
What is CUSIP 462260100?
CUSIP 462260100 identifies IOVA - IOVANCE BIOTHERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 462260100:
Top shareholders of IOVA - IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Wayne P. Rothbaum |
3/4/5
|
Director |
—
mixed-class rows
|
28,167,333
mixed-class rows
|
$257,731,097 | — | 01 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.6%
|
25,950,644
|
$208,124,165 | — | 30 Jun 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
6.6%
|
25,933,142
|
$207,983,798 | — | 30 Jun 2024 | |
| MHR FUND MANAGEMENT LLC |
13F
|
Company |
6.1%
|
23,997,103
|
$192,456,766 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.4%
|
21,225,119
|
$170,225,456 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
3.2%
|
12,625,177
|
$101,253,920 | — | 30 Jun 2024 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
3%
|
11,700,000
|
$93,834,000 | — | 30 Jun 2024 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
1.9%
|
7,548,000
|
$60,534,960 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
5,786,532
|
$46,416,921 | — | 30 Jun 2024 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
1.3%
|
5,111,409
|
$40,993,500 | — | 30 Jun 2024 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
1.1%
|
4,540,560
|
$36,415,291 | — | 30 Jun 2024 | |
| Long Focus Capital Management, LLC |
13F
|
Company |
1%
|
4,132,000
|
$33,138,640 | — | 30 Jun 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.88%
|
3,482,402
|
$27,930,000 | — | 30 Jun 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.87%
|
3,438,232
|
$27,574,620 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.71%
|
2,822,863
|
$22,639,362 | — | 30 Jun 2024 | |
| Hood River Capital Management LLC |
13F
|
Company |
0.69%
|
2,732,427
|
$21,914,065 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.66%
|
2,621,784
|
$21,026,708 | — | 30 Jun 2024 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.64%
|
2,536,243
|
$20,340,588 | — | 30 Jun 2024 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.63%
|
2,491,659
|
$19,983,105 | — | 30 Jun 2024 | |
| MPM BioImpact LLC |
13F
|
Company |
0.6%
|
2,366,714
|
$18,981,046 | — | 30 Jun 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.57%
|
2,265,555
|
$18,169,623 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.55%
|
2,167,225
|
$17,381,146 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.55%
|
2,166,958
|
$17,379,004 | — | 30 Jun 2024 | |
| Palo Alto Investors LP |
13F
|
Company |
0.54%
|
2,116,403
|
$16,973,552 | — | 30 Jun 2024 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
0.52%
|
2,050,500
|
$16,446,000 | — | 30 Jun 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.5%
|
1,994,500
|
$15,995,888 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.5%
|
1,984,945
|
$15,919,259 | — | 30 Jun 2024 | |
| EAGLE ASSET MANAGEMENT INC |
13F
|
Company |
0.49%
|
1,937,709
|
$15,617,934 | — | 30 Jun 2024 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.41%
|
1,636,025
|
$13,120,921 | — | 30 Jun 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.41%
|
1,612,055
|
$12,928,681 | — | 30 Jun 2024 | |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC |
13F
|
Company |
0.39%
|
1,555,408
|
$12,474,372 | — | 30 Jun 2024 | |
| 683 Capital Management, LLC |
13F
|
Company |
0.38%
|
1,500,000
|
$12,030,000 | — | 30 Jun 2024 | |
| BRAIDWELL LP |
13F
|
Company |
0.37%
|
1,466,610
|
$11,762,212 | — | 30 Jun 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.34%
|
1,328,117
|
$10,651,498 | — | 30 Jun 2024 | |
| C WorldWide Group Holding A/S |
13F
|
Company |
0.32%
|
1,260,000
|
$10,105,000 | — | 30 Jun 2024 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.31%
|
1,208,867
|
$9,695,113 | — | 30 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.26%
|
1,034,760
|
$8,298,774 | — | 30 Jun 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.26%
|
1,030,312
|
$8,263,103 | — | 30 Jun 2024 | |
| Artal Group S.A. |
13F
|
Company |
0.26%
|
1,011,500
|
$8,112,230 | — | 30 Jun 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.25%
|
991,649
|
$7,953,025 | — | 30 Jun 2024 | |
| NORGES BANK |
13F
|
Company |
0.24%
|
942,983
|
$7,562,724 | — | 30 Jun 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.23%
|
920,077
|
$7,379,018 | — | 30 Jun 2024 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
0.23%
|
920,000
|
$7,378,400 | — | 30 Jun 2024 | |
| Opaleye Management Inc. |
13F
|
Company |
0.23%
|
897,000
|
$7,193,940 | — | 30 Jun 2024 | |
| UBS Group AG |
13F
|
Company |
0.2%
|
795,204
|
$6,377,536 | — | 30 Jun 2024 | |
| Orion Investment Co |
13F
|
Company |
0.2%
|
794,700
|
$6,373,494 | — | 30 Jun 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.2%
|
774,783
|
$6,213,760 | — | 30 Jun 2024 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.19%
|
769,160
|
$6,168,663 | — | 30 Jun 2024 | |
| Boxer Capital, LLC |
13F
|
Company |
0.19%
|
750,000
|
$6,015,000 | — | 30 Jun 2024 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.19%
|
731,607
|
$5,867,488 | — | 30 Jun 2024 |
Institutional Holders of IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) as of Q3 2024
As of 30 Sep 2024,
IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) was held by
280 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
235,201,336 shares.
The largest 10 holders included
VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, MHR FUND MANAGEMENT LLC, BlackRock, Inc., STATE STREET CORP, Soleus Capital Management, L.P., Hood River Capital Management LLC, T. Rowe Price Investment Management, Inc., GEODE CAPITAL MANAGEMENT, LLC, and Artisan Partners Limited Partnership.
This page lists
281
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
287
Q3 2024 holders
280
Holder diff
-7
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.